Preprint
Article

This version is not peer-reviewed.

Galactosylation of Cosmetic Preservatives to Reduce Skin Permeation and Cytotoxicity

Submitted:

01 May 2026

Posted:

04 May 2026

You are already at the latest version

Abstract
Cosmetic preservatives should have reduced percutaneous absorption to lower the risk of systemic exposure and skin irritation. In this work, Escherichia coli β-galactosidase was used to enzymatically modify several of the commonly used cosmetic preservatives to produce their corresponding galactosylated derivatives: benzyl alcohol β-D-galactopyranoside 7, 2-phenoxyethanol β-D-galactopyranoside 8, chlorphenesin β-D-galactopyranoside 9, 1,2-hexanediol β-D-galactopyranoside 10, 1,2-octanediol β-D-galactopyranoside 11, and 2-phenylethyl β-D-galactopyranoside 12. HPLC and NMR spectroscopy were used to analyze the synthesized derivatives. The Franz diffusion cell assay was used to evaluate skin penetration. 2-phenoxyethanol (PE), chlorphenesin (CPN), and 2-phenylethanol (PhE), exhibited measurable skin penetration with flux values ranging from 3.82 to 7.34 µg·h⁻¹·cm⁻² and permeability coefficients (Kp) between 1.38 and 3.00 ×10⁻³ cm·h⁻¹. In contrast, their galactosylated derivatives showed markedly reduced permeation under the same experimental conditions. Moreover, brine shrimp lethality assays indicated that galactosylated derivatives had significantly higher LD₅₀ values (1.6–2.1 mg/mL) than their parent compounds (0.1–0.79 mg/mL), suggesting lower cytotoxicity. These findings suggest that enzymatic galactosylation can significantly decrease skin permeability and the toxicity of cosmetic preservatives, highlighting its potential as a strategy to improve the safety of cosmetic ingredients.
Keywords: 
;  ;  ;  ;  ;  ;  
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Prerpints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

Subscribe

Disclaimer

Terms of Use

Privacy Policy

Privacy Settings

© 2026 MDPI (Basel, Switzerland) unless otherwise stated